| |
Home »
Medical Search » Medical Briefings » A Tour around Toxoplasmosis
A Tour around Toxoplasmosis
Read about
Toxoplasmosis
A Tour around Toxoplasmosis
(Date of publication 24 March 2005)
Has one of your male neighbours recently started driving recklessly,
gambling wildly or become something of a delinquent? If so, one possible
explanation is chronic infection with the parasitic protozoon Toxoplasma
gondii. This condition is common all over the world and one effect in men is a
personality change, so that the sufferer loses control, disregards rules and
follows urges, whilst simultaneously becoming detached, critical and dogmatic.
To find out why, we need to look at the organism's life cycle.
The
definitive host for T. gondii is the cat, with rats and mice being common
intermediate hosts. When rodents become infected, certain behavioural changes
are induced: decreases in motor performance, learning capacity and fear, and
increases in activity and reaction times. These are considered to be
evolutionary adaptations of the parasite to facilitate transmission from
intermediate to definitive host by increasing predation. When the intermediate
host is man rather than a rodent, these effects are obviously redundant, but
one documented consequence is a significantly higher risk of traffic accidents.
There may also be an association with the development of psychoses.
T.
gondii is an obligate intracellular parasite with similar properties to the
pathogen causing malaria. The complete life cycle is shown in this diagram and
photomicrographs of the various developmental stages can be found here. Humans
are usually infected by accidentally ingesting traces of faeces from an
infected cat that is shedding the organism, or by eating undercooked meat from
another intermediate host that contains cysts. Ingestion of tissue cysts or
oocysts is followed by the infection of intestinal epithelial cells. After
becoming tachyzoites, the organisms are disseminated throughout the body via
the blood or lymphatic system. Once the peripheral tissues are reached, they
transform into tissue cysts which appear to persist for the life of the host.
Most people are unaware of becoming infected and remain asymptomatic,
although a proportion develop 'flu-like' symptoms with swollen lymph glands and
muscle pains that may last for a month or more. The disease then typically
becomes latent when the cysts which contain bradyzoites develop,
most frequently in the brain and skeletal and cardiac muscle. These typically
cause little or no inflammatory response and treatment is not required.
However, infection can be reactivated subsequently, particularly if the host
becomes immunocompromised as a result of malignancy, AIDS or organ
transplantation.
Toxoplasmosis can be particularly serious in HIV
patients, where it is typically caused by reactivation of a chronic infection
and manifests primarily as toxoplasmic encephalitis. This condition is an
important cause of focal brain lesions in patients with HIV; here is a CT scan
demonstrating multiple enhancing brainstem lesions, and here a photograph of a
brain slice with multiple T. gondii abscesses. Toxoplasmic encephalitis
characteristically has a subacute onset with focal neurologic abnormalities,
and is frequently accompanied by headache, altered mental status and fever. The
most common focal signs are motor weakness and speech disturbances, but
patients may also present with seizures, visual field defects and sensory
disturbances. Victims generally have CD4 T-cell counts <100/µL. If you
are particularly interested in the diagnosis of toxoplasmosis, this site has a
detailed section covering serology, CSF studies, DNA detection, isolation
studies, neuroradiological studies and histopathology. Treatment usually
consists of a combination of pyrimethamine and sulphadiazine, which exhibit
synergistic activity against folic acid synthesis by the parasite. Around half
the people who take sulphadiazine have an allergic reaction to it, but this can
be overcome by using a desensitisation procedure.
The other group of
people particularly at risk is pregnant women; their babies stand a 40% chance
of being affected if the mothers contract toxoplasmosis during pregnancy.
According to the Organization of Tetralogy Information Services, 'Congenital
toxoplasmosis only occurs when the mother has an active infection during
pregnancy. In general, there is no increased risk to the foetus when
toxoplasmosis occurred more than 6 months prior to conception.' The sequellae
of in utero infection can be blindness, epilepsy and impaired mental
development.
An estimated 400 4,000 cases of foetal toxoplasmosis
occur in the United States each year. While some affected babies exhibit the
classic signs of chorioretinitis, hydrocephalus and intracranial
calcifications, most have no obvious signs of toxoplasmosis. However, up to 80%
develop visual or learning difficulties later in life. Although this site only
recommends the screening of pregnant women who are at high risk, or those in
whom routine ultrasound examinations have revealed foetal abnormalities, a very
recent US study found that signs, symptoms and identifiable risk factors were
absent in more than half the mothers of infants with congenital toxoplasmosis.
Consequently, the authors recommend screening all pregnant women and all
newborn infants.
Other research has focused on avidity testing,
measuring the capacity of the toxoplasmosis antibody to bind to the
corresponding antigen, and found that it is weak soon after infection but
becomes very strong after 16 weeks. This technique can therefore pinpoint the
time of infection and, critically, whether it occurred before or after
conception. Perhaps even more importantly, a method has now been developed to
deliver medication directly to T. gondii within cysts, providing a totally new
target for anti-parasitic treatment.
Read about
Toxoplasmosis
|
This medical briefing was written by
Derrick Garwood, a Freelance Medical Writer and Editor, and first published, on
this same date, in the series of InPharm Tours at
InPharm.com. It is
reproduced here with permission from the publishers.
The links presented here were accurate at the time of
publication, but remember that information on the Web has a tendancy to change
without notice! |
Disclaimer
Net Media Marketing excludes any
warranty, express or implied, as to the quality, accuracy, timeliness,
completeness or fitness for a particular purpose of this briefing. Net Media
Marketing will not be liable for any claims, penalties, losses, damages, costs,
or expenses arising from the use of or inability to use this briefing or from
any unauthorised access to or alteration of the Briefing. Net Media Marketing
makes no warranty that the contents of this briefing are compatible with all
computer systems and browsers.
Pharmaceutical Jobs, All
jobs & Vacancies, Pharmaceutical sales jobs,
Healthcare sales jobs,
Laboratory sales jobs,
Veterinary sales jobs,
Dental sales jobs,
Trainee
medical sales jobs, Nurse Advisor
jobs, Sales Management
jobs, Marketing
jobs, Senior Management
jobs, Regulatory &
Clinical jobs, Scientific Sales
Jobs, British National Formulary (BNF),
British Pharmacopoeia
(BP)
|